Company: ARWR
Filing Date: 2025-01-29
Form Type: DEF 14A
Source: 0001628280-25-002848
Chunk: 58

Company: ARROWHEAD PHARMACEUTICALS, INC.
Filing Date: 2025-01-29
Form: DEF 14A
Chunk 58
---
 Four must be approved by the Required Vote, assuming a quorum is present. For this purpose, abstentions and broker non-votes, if any, will be counted as a vote “AGAINST” the proposal.

| THE BOARD UNANIMOUSLY RECOMMENDS A VOTE 
 “FOR”PROPOSAL FOUR.                     |

| 58 |

2025 PROXY STATEMENT Audit Fees Audit Fees The Audit Committee regularly reviews and determines whether specific projects or expenditures with our independent auditors may potentially affect their independence. The Audit Committee’s policy is to pre-approve all audit and permissible non-audit services provided by our independent auditors. Pre-approval is generally provided by the Audit Committee for up to one year, detailed to the particular service or category of services to be rendered and is generally subject to a specific budget. The Audit Committee may also pre-approve additional services of specific engagements on a case-by-case basis. All engagements of our independent registered public accounting firm in 2024 and 2023 were pre-approved by the audit committee. The following table sets forth the aggregate audit fees and other services provided during the indicated fiscal years. These include amounts billed and expected to be billed by our current independent auditors, KPMG, for fiscal year 2024, and by our former independent auditors, RS&J, for fiscal year 2023:

|                        |     | Year Ended September  30, |       2024 |     |     |     2023 |
|:-----------------------|:----|:--------------------------|-----------:|:----|:----|---------:|
| Audit fees (1)         |     |                           |   $860,000 |     |     | $414,250 |
| Audit-related fees (2) |     |                           |    150,000 |     |     |  226,100 |
| Tax Fees               |     |                           |          — |     |     |        — |
| All other fees         |     |                           |          — |     |     |        — |
| Total                  |     |                           | $1,010,000 |     |     | $640,350 |

(1) Fees invoiced by KPMG and RS&J include year-end audit and periodic reviews of Forms 10-Q and 10-K. (2) Fees invoiced by KPMG and RS&J related to Comfort Letters and Consents for financings and registration statements, and other agreed-upon